Iniziativa
Trial clinico Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants with Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria) – NCT06087835
Referente attività: Raffaella Buzzetti
Area di intervento: Salute pubblica e benessere
Durata dell’iniziativa: 2025-01-01
